CD8A and non-small cell lung carcinoma: intracellular PD-L1 governs NSCLC cell proliferation, metastasis, cisplatin resistance, and CSCs properties, while extracellular PD-L1 provokes the deactivation of CD8+ T cells to avoid immune clearance (59).